| Literature DB >> 26024662 |
José F Rodríguez-Palomares1,2,3, José T Ortiz-Pérez4, Daniel C Lee4,5, Chiara Bucciarelli-Ducci4,6, Paula Tejedor4, Robert O Bonow4, Edwin Wu4,5.
Abstract
BACKGROUND: In acute myocardial infarction (MI), late Gadolinium enhancement (LGE) has been proposed to include the infarcted myocardium and area at risk. However, little information is available on the optimal timing after contrast injection to differentiate these 2 areas. Our aim was to determine in acute and chronic MI whether imaging time after contrast injection influences the LGE size that better predicts infarct size and functional recovery.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26024662 PMCID: PMC4449586 DOI: 10.1186/s12968-015-0139-8
Source DB: PubMed Journal: J Cardiovasc Magn Reson ISSN: 1097-6647 Impact factor: 5.364
Clinical characteristics for all subjects (n = 60)
|
| |
| Age (years)1 | 57 ± 10 |
| Male | 49 (81.67%) |
| Diabetes mellitus | 3 (5%) |
| Hypertension | 25 (41.67%) |
| Hypercholesterolemia | 30 (50%) |
| Tobacco use | 30 (50%) |
|
| |
| Symptom-to-balloon ( | 197 |
| Door-to-balloon ( | 85.5 |
| Maximum total CK MB (IU/L)1 | 243.65 ± 239.64 |
| Maximum total Troponine T (ng/L)1 | 53.43 ± 80.65 |
|
| |
| Left anterior descending IRA | 33 (55%) |
| Left circumflex IRA | 6 (10%) |
| Right coronary IRA | 21 (35%) |
|
| |
| TIMI 0 | 43 (71.67%) |
| TIMI 1 | 10 (16.67%) |
| TIMI 2 | 5 (8.33%) |
| TIMI 3 | 2 (3.33%) |
|
| |
| TIMI 2 | 7 (11.67%) |
| TIMI 3 | 53 (88.33%) |
|
| |
| 0 | 22 (36.67%) |
| 1 | 16 (26.67%) |
| 2 | 15 (25%) |
| 3 | 7 (11.67%) |
|
| |
|
| |
| End-diastolic volume (mL)1 | 154.35 ± 30.72 |
| End-systolic volume (mL)1 | 85.14 ± 29.55 |
| Ejection Fraction (%)1 | 45.83 ± 11.47 |
| Infarct mass (gr)1 | 24.12 ± 16.15 |
|
| |
| End-diastolic volume (mL)1 | 161.65 ± 30.73 |
| End-systolic volume (mL)1 | 79.12 ± 28.13 |
| Ejection Fraction (%)1 | 52.16 ± 10.82 |
| Infarct mass (gr)1 | 13.74 ± 10.46 |
|
| |
| IIB-IIIA inhibitor | 58 (96.67%) |
| Antiplatelet (aspirine and/or clopidogrel) | 58 (96.67%) |
| β-Blocker | 58 (96.67%) |
| ACE inhibitor | 51 (85%) |
| Statin | 56 (94%) |
Data expressed as mean (percentages). 1Data expressed as mean and standard deviation.
Fig. 1Relationship between the inversion time in the acute and chronic CMR over time after contrast administration
Fig. 2Relationship between the signal intensity in the left ventricular (LV) cavity, the infarcted and remote regions and the time after bolus injection in the acute (2A) and chronic CMR (2B)
LGE and MVO volumes at different time points after the administration of the contrast in acute and chronic CMR
| Minutes | Acute LGE volume (grams) | Acute MVO volume (grams) | Chronic LGE volume (grams) |
|---|---|---|---|
| 1st | 22.49 ± 15.13 | 6.31 ± 10.92 | 10.68 ± 7.48 |
| 3rd | 25.99 ± 14.64 | 5.07 ± 10.46 (19.51%)* | 11.29 ± 6.86 |
| 5th | 24.13 ± 14.32 | 3.98 ± 8.26 (36.93%)* | 11.99 ± 7.93 |
| 7th | 23.86 ± 14.43 | 3.50 ± 8.20 (44.53%)* | 11.77 ± 8.39 |
| 10th | 22.67 ± 13.77 | 2.77 ± 7.42 (56.10%)* | 12.02 ± 8.17 |
| 15th | 22.20 ± 13.61 | 2.05 ± 6.40 (67.52%)* | 11.75 ± 7.81 |
| 20th | 21.19 ± 12.62 | 1.81 ± 6.66 (71.32%)* | 10.92 ± 7.12 |
| 25th | 20.22 ± 12.41 | 0.79 ± 2.67 (87.32%)* | 10.75 ± 7.21 |
Data expressed as mean and standard deviation. *Data expressed as percentage of reduction.
Fig. 3Dynamic changes of late Gadolinium enhancement volume over time after contrast injection in acute and chronic CMR (3A) and also in the presence of early and late microvascular obstruction (3B). Representative images of the changes in late Gadolinium and microvascular obstruction volumes in 3 patients (each patient is represented in a row) at different time points (3, 10 and 25 minutes after the administration of the contrast) (3C)
Fig. 4Dynamic changes of the transmurality index and the infarct-ESA over time after contrast administration
Fig. 5Late Gadolinium enhancement volume obtained by single-shot sequences analyzed using different thresholds (2, 3, 4 and 5 standard deviation over remote signal intensity) in acute and chronic CMR
Change of the transmurality index over time (in minutes) after the administration of the contrast in acute CMR
| Transmurality index | ||||
|---|---|---|---|---|
|
|
|
|
|
|
|
| 8 (13.33%) | 13 (21.67%) | 21 (35%) | 18 (30%) |
|
| 2 (3.33%) | 10(16.67%) | 24 (40%) | 24 (40%) |
|
| 2 (3.33%) | 9 (15%) | 32 (53.33%) | 17 (28.33%) |
|
| 1 (1.67%) | 12 (20%) | 30 (50%) | 17 (28.33%) |
|
| 1 (1.67%) | 15 (25%) | 29 (48.33%) | 15 (25%) |
|
| 1 (1.67%) | 14 (23.33%) | 32 (53.33%) | 13 (21.67%) |
|
| 1 (1.67%) | 19 (31.67%) | 30 (50%) | 10 (16.67%) |
|
| 1 (1.67%) | 21 (35%) | 31 (51.67%) | 7 (11.67%) |
Data expressed as number of patients with a certain degree of transmurality index (percentages). Min = minutes.
Fig. 66A: Variation of the wall motion score index (WMSI) from acute CMR to chronic CMR according to the degree of transmurality (assessed 10 or 25 minutes after the contrast injection). Note that there is a significant improvement in the WMSI at follow-up except when the transmurality index is > 75% and assessed at 25 minutes. 6B/6C/6D: End-diastolic (B), end-systolic (C) volumes and ejection fraction (D) at follow-up according to the degree of transmurality assessed in the acute CMR at 10 and 25 min post-contrast. Note that only patients with a transmurality index > 75% measured 25 minutes post-contrast present a significant increase in the end-diastolic and end-systolic volumes and a significant decrease in the ejection fraction at follow-up. rohandkumar1@ucla.edu
Variation of CMR variables at follow-up in patients with a transmurality index > 75% (in the acute CMR) at different minutes post-contrast
| Time | N | Δ WMSI | Δ Num segments | Δ EDV (%) | Δ ESV (%) | Δ EF (%) |
|---|---|---|---|---|---|---|
|
| 18 (30%)1 | 2.90 ± 3.60 | 2.30 ± 2.21 | 12.73 ± 21.99 | 13.21 ± 43.06 | −4.48 ± 31.23 |
|
| 24 (40%)1 | 4.93 ± 4.68 | 4.90 ± 2.56 | 9.87 ± 22.78 | 3.44 ± 40.08 | 3.48 ± 28.79 |
|
| 17 (28.33%)1 | 4.20 ± 3.01 | 4.80 ± 1.85 | 15.67 ± 22.55 | 15.84 ± 45.52 | −0.47 ± 33.72 |
|
| 17 (28.33%)1 | 4.12 ± 4.36 | 4.55 ± 2.31 | 14.01 ± 28.71 | 14.79 ± 44.85 | −2.59 ± 33.49 |
|
| 15 (25%)1 | 4.00 ± 4.78 | 4.25 ± 2.76 | 14.64 ± 25.56 | 11.08 ± 40.57 | −2.01 ± 33.66 |
|
| 13 (21.67%)1 | 3.60 ± 5.03 | 3.20 ± 2.59 | 17.47 ± 24.60 | 17.05 ± 40.38 | −4.38 ± 36.16 |
|
| 10 (16.67%)1 | 2.60 ± 3.78 | 2.60 ± 1.67 | 20.47 ± 30.93 | 24.81 ± 45.67 | −8.75 ± 39.56 |
|
| 7 (11.67%)1 | 2.00 ± 3.50 | 2.00 ± 1.97 | 22.72 ± 27.52 | 26.15 ± 40.31 | −10.27 ± 40.40 |
N: expresses the number of patients with a transmurality index > 75% in the acute CMR. Δ: expresses the change of the variables from the acute to the chronic CMR.
Data expressed as mean and standard deviation.1Data expressed as mean (percentages).
Min: minutes. WMSI: Wall motion score index. Num: number. EDV: end-diastolic volume. ESV: end-systolic volume. EF: ejection fraction.